Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06682312 · ClinicalTrials.gov registry record
Philips Non-Invasive Blood Pressure Validation Study
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Terminated
- Registry status
- 89
- Enrollment target
NCT06682312: Clinical Trial study, sponsored by Philips Clinical & Medical Affairs Global.
NCT06682312 is a clinical trial that was terminated before completion, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 89 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06682312 was terminated before completion, sponsored by Philips Clinical & Medical Affairs Global.
- TERMINATED
- Registry status
- 89 participants
- Enrollment target
Study Summary
The purpose of this study is to provide supporting documentation of the blood pressure performance for the Philips EarlyVue VS30 monitor on the intended adult and pediatric population. The same arm sequential method with dual observer auscultation will be used to collect data.
Primary Outcome
The primary objective of this study is to provide a validation following ISO 81060-2:2018/AMD 2:2024 for noninvasive blood pressure measurement accuracy for the Philips EarlyVue VS30 on the intended population. The EarlyVue VS30 will be compared to the reference sphygmomanometer via same arm sequential method with dual auscultators. The end goal is to pass the Criterion 1 and Criterion 2 of ISO 81060-2:2018/AMD 2:2024 Criterion 1 * Mean Error of individual paired determinations ≤ ±5.0 mmHg * S
Interventions
- DEVICE Non-invasive blood pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2024-10-14 |
| Est. Completion | 2024-10-23 |
Why NCT06682312 stopped before completion
NCT06682312 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 89 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Non-invasive blood pressure is the first listed.
NCT06682312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06682312 about?
NCT06682312 is a clinical study titled "Philips Non-Invasive Blood Pressure Validation Study". The purpose of this study is to provide supporting documentation of the blood pressure performance for the Philips EarlyVue VS30 monitor on the intended adult and pediatric population. The same arm sequential method with dual observer auscultation will be used to collect data.
What is the current status of trial NCT06682312?
This trial is currently terminated. The enrollment target is 89 participants. The study started on 2024-10-14. Estimated completion is 2024-10-23.
What interventions are being tested in trial NCT06682312?
The interventions under investigation include: Non-invasive blood pressure (DEVICE).
Who is sponsoring clinical trial NCT06682312?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI